Amgen’s Bob Bradway takes slight salary dip amid higher pay among US execs

Amgen released its executive compensation numbers late last week, and while the filing trailed behind other Big Pharmas and biotech companies such as Pfizer, Moderna, J&J, Sanofi and Horizon, Bob Bradway made more than many in 2022, pulling in just shy of $21.4 million. Bradway’s income dropped about $320,000 compared…